The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Cardiopulmonary Autotransfusion System Market Research Report 2024
Synopsis
Cardiopulmonary Autotransfusion System is a sophisticated device with an exceptionally effective design that provides autologous blood during surgical procedures.
Autotransfusion is a process wherein a person receives their own blood for a transfusion, instead of banked allogenic (separate-donor) blood. There are two main kinds of Autotransfusion: Blood can be autologous "pre-donated" (termed so despite "donation" not typically referring to giving to one's self) before a surgery, or alternatively, it can be collected during and after the surgery using an intraoperative blood salvage device. The latter form of Autotransfusion is utilized in surgeries where there is expected a large volume blood loss.
The global Cardiopulmonary Autotransfusion System market was valued at US$ 553 million in 2023 and is anticipated to reach US$ 654.2 million by 2030, witnessing a CAGR of 2.4% during the forecast period 2024-2030.
The major players in global Cardiopulmonary Autotransfusion System market include Haemonetics, Medtronic, LivaNova, etc. The top 3 players occupy about 70% shares of the global market. North America and Europe are main markets, they occupy about 80% of the global market. Washed ATS is the main type, with a share about 90%. Heart Surgery is the main application, which holds a share about 35%.
This report aims to provide a comprehensive presentation of the global market for Cardiopulmonary Autotransfusion System, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cardiopulmonary Autotransfusion System.
Report Scope
The Cardiopulmonary Autotransfusion System market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Cardiopulmonary Autotransfusion System market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Cardiopulmonary Autotransfusion System manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Haemonetics
Medtronic
LivaNova
Fresenius Kabi
Terumo
Wandong Health Sources
Segment by Type
Unwashed ATS
Washed ATS
Segment by Application
Heart Surgery
Great Organ Transplant Surgery
Other Surgery
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Cardiopulmonary Autotransfusion System manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Cardiopulmonary Autotransfusion System in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Cardiopulmonary Autotransfusion System is a sophisticated device with an exceptionally effective design that provides autologous blood during surgical procedures.
Autotransfusion is a process wherein a person receives their own blood for a transfusion, instead of banked allogenic (separate-donor) blood. There are two main kinds of Autotransfusion: Blood can be autologous "pre-donated" (termed so despite "donation" not typically referring to giving to one's self) before a surgery, or alternatively, it can be collected during and after the surgery using an intraoperative blood salvage device. The latter form of Autotransfusion is utilized in surgeries where there is expected a large volume blood loss.
The global Cardiopulmonary Autotransfusion System market was valued at US$ 553 million in 2023 and is anticipated to reach US$ 654.2 million by 2030, witnessing a CAGR of 2.4% during the forecast period 2024-2030.
The major players in global Cardiopulmonary Autotransfusion System market include Haemonetics, Medtronic, LivaNova, etc. The top 3 players occupy about 70% shares of the global market. North America and Europe are main markets, they occupy about 80% of the global market. Washed ATS is the main type, with a share about 90%. Heart Surgery is the main application, which holds a share about 35%.
This report aims to provide a comprehensive presentation of the global market for Cardiopulmonary Autotransfusion System, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cardiopulmonary Autotransfusion System.
Report Scope
The Cardiopulmonary Autotransfusion System market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Cardiopulmonary Autotransfusion System market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Cardiopulmonary Autotransfusion System manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Haemonetics
Medtronic
LivaNova
Fresenius Kabi
Terumo
Wandong Health Sources
Segment by Type
Unwashed ATS
Washed ATS
Segment by Application
Heart Surgery
Great Organ Transplant Surgery
Other Surgery
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Cardiopulmonary Autotransfusion System manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Cardiopulmonary Autotransfusion System in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Cardiopulmonary Autotransfusion System Market Overview
1.1 Product Overview and Scope of Cardiopulmonary Autotransfusion System
1.2 Cardiopulmonary Autotransfusion System Segment by Type
1.2.1 Global Cardiopulmonary Autotransfusion System Market Value Comparison by Type (2024-2030)
1.2.2 Unwashed ATS
1.2.3 Washed ATS
1.3 Cardiopulmonary Autotransfusion System Segment by Application
1.3.1 Global Cardiopulmonary Autotransfusion System Market Value by Application: (2024-2030)
1.3.2 Heart Surgery
1.3.3 Great Organ Transplant Surgery
1.3.4 Other Surgery
1.4 Global Cardiopulmonary Autotransfusion System Market Size Estimates and Forecasts
1.4.1 Global Cardiopulmonary Autotransfusion System Revenue 2019-2030
1.4.2 Global Cardiopulmonary Autotransfusion System Sales 2019-2030
1.4.3 Global Cardiopulmonary Autotransfusion System Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Cardiopulmonary Autotransfusion System Market Competition by Manufacturers
2.1 Global Cardiopulmonary Autotransfusion System Sales Market Share by Manufacturers (2019-2024)
2.2 Global Cardiopulmonary Autotransfusion System Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Cardiopulmonary Autotransfusion System Average Price by Manufacturers (2019-2024)
2.4 Global Cardiopulmonary Autotransfusion System Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Cardiopulmonary Autotransfusion System, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Cardiopulmonary Autotransfusion System, Product Type & Application
2.7 Cardiopulmonary Autotransfusion System Market Competitive Situation and Trends
2.7.1 Cardiopulmonary Autotransfusion System Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Cardiopulmonary Autotransfusion System Players Market Share by Revenue
2.7.3 Global Cardiopulmonary Autotransfusion System Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Cardiopulmonary Autotransfusion System Retrospective Market Scenario by Region
3.1 Global Cardiopulmonary Autotransfusion System Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Cardiopulmonary Autotransfusion System Global Cardiopulmonary Autotransfusion System Sales by Region: 2019-2030
3.2.1 Global Cardiopulmonary Autotransfusion System Sales by Region: 2019-2024
3.2.2 Global Cardiopulmonary Autotransfusion System Sales by Region: 2025-2030
3.3 Global Cardiopulmonary Autotransfusion System Global Cardiopulmonary Autotransfusion System Revenue by Region: 2019-2030
3.3.1 Global Cardiopulmonary Autotransfusion System Revenue by Region: 2019-2024
3.3.2 Global Cardiopulmonary Autotransfusion System Revenue by Region: 2025-2030
3.4 North America Cardiopulmonary Autotransfusion System Market Facts & Figures by Country
3.4.1 North America Cardiopulmonary Autotransfusion System Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Cardiopulmonary Autotransfusion System Sales by Country (2019-2030)
3.4.3 North America Cardiopulmonary Autotransfusion System Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Cardiopulmonary Autotransfusion System Market Facts & Figures by Country
3.5.1 Europe Cardiopulmonary Autotransfusion System Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Cardiopulmonary Autotransfusion System Sales by Country (2019-2030)
3.5.3 Europe Cardiopulmonary Autotransfusion System Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Cardiopulmonary Autotransfusion System Market Facts & Figures by Country
3.6.1 Asia Pacific Cardiopulmonary Autotransfusion System Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Cardiopulmonary Autotransfusion System Sales by Country (2019-2030)
3.6.3 Asia Pacific Cardiopulmonary Autotransfusion System Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Cardiopulmonary Autotransfusion System Market Facts & Figures by Country
3.7.1 Latin America Cardiopulmonary Autotransfusion System Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Cardiopulmonary Autotransfusion System Sales by Country (2019-2030)
3.7.3 Latin America Cardiopulmonary Autotransfusion System Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Cardiopulmonary Autotransfusion System Market Facts & Figures by Country
3.8.1 Middle East and Africa Cardiopulmonary Autotransfusion System Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Cardiopulmonary Autotransfusion System Sales by Country (2019-2030)
3.8.3 Middle East and Africa Cardiopulmonary Autotransfusion System Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Cardiopulmonary Autotransfusion System Sales by Type (2019-2030)
4.1.1 Global Cardiopulmonary Autotransfusion System Sales by Type (2019-2024)
4.1.2 Global Cardiopulmonary Autotransfusion System Sales by Type (2025-2030)
4.1.3 Global Cardiopulmonary Autotransfusion System Sales Market Share by Type (2019-2030)
4.2 Global Cardiopulmonary Autotransfusion System Revenue by Type (2019-2030)
4.2.1 Global Cardiopulmonary Autotransfusion System Revenue by Type (2019-2024)
4.2.2 Global Cardiopulmonary Autotransfusion System Revenue by Type (2025-2030)
4.2.3 Global Cardiopulmonary Autotransfusion System Revenue Market Share by Type (2019-2030)
4.3 Global Cardiopulmonary Autotransfusion System Price by Type (2019-2030)
5 Segment by Application
5.1 Global Cardiopulmonary Autotransfusion System Sales by Application (2019-2030)
5.1.1 Global Cardiopulmonary Autotransfusion System Sales by Application (2019-2024)
5.1.2 Global Cardiopulmonary Autotransfusion System Sales by Application (2025-2030)
5.1.3 Global Cardiopulmonary Autotransfusion System Sales Market Share by Application (2019-2030)
5.2 Global Cardiopulmonary Autotransfusion System Revenue by Application (2019-2030)
5.2.1 Global Cardiopulmonary Autotransfusion System Revenue by Application (2019-2024)
5.2.2 Global Cardiopulmonary Autotransfusion System Revenue by Application (2025-2030)
5.2.3 Global Cardiopulmonary Autotransfusion System Revenue Market Share by Application (2019-2030)
5.3 Global Cardiopulmonary Autotransfusion System Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Haemonetics
6.1.1 Haemonetics Corporation Information
6.1.2 Haemonetics Description and Business Overview
6.1.3 Haemonetics Cardiopulmonary Autotransfusion System Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Haemonetics Cardiopulmonary Autotransfusion System Product Portfolio
6.1.5 Haemonetics Recent Developments/Updates
6.2 Medtronic
6.2.1 Medtronic Corporation Information
6.2.2 Medtronic Description and Business Overview
6.2.3 Medtronic Cardiopulmonary Autotransfusion System Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Medtronic Cardiopulmonary Autotransfusion System Product Portfolio
6.2.5 Medtronic Recent Developments/Updates
6.3 LivaNova
6.3.1 LivaNova Corporation Information
6.3.2 LivaNova Description and Business Overview
6.3.3 LivaNova Cardiopulmonary Autotransfusion System Sales, Revenue and Gross Margin (2019-2024)
6.3.4 LivaNova Cardiopulmonary Autotransfusion System Product Portfolio
6.3.5 LivaNova Recent Developments/Updates
6.4 Fresenius Kabi
6.4.1 Fresenius Kabi Corporation Information
6.4.2 Fresenius Kabi Description and Business Overview
6.4.3 Fresenius Kabi Cardiopulmonary Autotransfusion System Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Fresenius Kabi Cardiopulmonary Autotransfusion System Product Portfolio
6.4.5 Fresenius Kabi Recent Developments/Updates
6.5 Terumo
6.5.1 Terumo Corporation Information
6.5.2 Terumo Description and Business Overview
6.5.3 Terumo Cardiopulmonary Autotransfusion System Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Terumo Cardiopulmonary Autotransfusion System Product Portfolio
6.5.5 Terumo Recent Developments/Updates
6.6 Wandong Health Sources
6.6.1 Wandong Health Sources Corporation Information
6.6.2 Wandong Health Sources Description and Business Overview
6.6.3 Wandong Health Sources Cardiopulmonary Autotransfusion System Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Wandong Health Sources Cardiopulmonary Autotransfusion System Product Portfolio
6.6.5 Wandong Health Sources Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Cardiopulmonary Autotransfusion System Industry Chain Analysis
7.2 Cardiopulmonary Autotransfusion System Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Cardiopulmonary Autotransfusion System Production Mode & Process
7.4 Cardiopulmonary Autotransfusion System Sales and Marketing
7.4.1 Cardiopulmonary Autotransfusion System Sales Channels
7.4.2 Cardiopulmonary Autotransfusion System Distributors
7.5 Cardiopulmonary Autotransfusion System Customers
8 Cardiopulmonary Autotransfusion System Market Dynamics
8.1 Cardiopulmonary Autotransfusion System Industry Trends
8.2 Cardiopulmonary Autotransfusion System Market Drivers
8.3 Cardiopulmonary Autotransfusion System Market Challenges
8.4 Cardiopulmonary Autotransfusion System Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
